Promentis Pharmaceuticals, Inc. raises $2.9 million

Promentis Pharmaceuticals, Inc., a Milwaukee company co-founded by Drs. David Baker and John Mantsch, professors of biomedical sciences in the College of Health Sciences, has raised $2.9 million in Series B financing. The company, which develops drugs to treat schizophrenia and other central nervous system disorders, will use the funds to bring two of the compounds into clinical trials for humans within the next two years.

Read More

Biomedical Sciences faculty receive $400,000 grant for neurological research

Dr. David Baker and Dr. SuJean Choi received a $400,000 grant from the National Institutes of Health to develop a powerful new molecular genetic tool to examine the role of a novel cellular mechanism in regulating neurotransmitter release in the brain.

Read More


Dr. David Baker receives Way Klingler Fellowship in science.

Dr. Douglas C. Lobner was honored with the Teaching Excellence Award

Student Receives AMUW Ignatian Leadership Award

Dr. David Baker delivers keynote addresses for NAMI

Record number of visitors tour anatomy facility

Researcher finds new target in brain for sedatives

Marquette pharmaceutical firm AviMed sign licensing agreement

Biomedical Sciences professor earns national recognition for research